AbbVie, Teva Accused Of Pay-For-Delay On Generic Niaspan
A union pension fund lodged an antitrust class action Thursday accusing AbbVie Inc. of paying off Teva Pharmaceuticals USA Inc. in a sham patent settlement to delay the release of a...To view the full article, register now.
Already a subscriber? Click here to view full article